Pharmaron Beijing Co Ltd
SZSE:300759

Watchlist Manager
Pharmaron Beijing Co Ltd Logo
Pharmaron Beijing Co Ltd
SZSE:300759
Watchlist
Price: 27.07 CNY -1.74%
Market Cap: 40.2B CNY
Have any thoughts about
Pharmaron Beijing Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Pharmaron Beijing Co Ltd stock under the Base Case scenario is 39.38 CNY. Compared to the current market price of 27.07 CNY, Pharmaron Beijing Co Ltd is Undervalued by 31%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
39.38 CNY
Undervaluation 31%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Pharmaron Beijing Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Pharmaron Beijing Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Pharmaron Beijing Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Pharmaron Beijing Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

27.07 CNY
-1.74%
-1.74%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Pharmaron Beijing Co Ltd
CN
Life Sciences Tools & Services
Market Cap
40.2B CNY
IPO
Jan 28, 2019
Employees
14 923
China
Market Cap
40.2B CNY
Industry
Life Sciences Tools & Services
IPO
Jan 28, 2019
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Pharmaron Beijing Co Ltd

Provide an overview of the primary business activities
of Pharmaron Beijing Co Ltd.

What unique competitive advantages
does Pharmaron Beijing Co Ltd hold over its rivals?

What risks and challenges
does Pharmaron Beijing Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Pharmaron Beijing Co Ltd.

Provide P/S
for Pharmaron Beijing Co Ltd.

Provide P/E
for Pharmaron Beijing Co Ltd.

Provide P/OCF
for Pharmaron Beijing Co Ltd.

Provide P/FCFE
for Pharmaron Beijing Co Ltd.

Provide P/B
for Pharmaron Beijing Co Ltd.

Provide EV/S
for Pharmaron Beijing Co Ltd.

Provide EV/GP
for Pharmaron Beijing Co Ltd.

Provide EV/EBITDA
for Pharmaron Beijing Co Ltd.

Provide EV/EBIT
for Pharmaron Beijing Co Ltd.

Provide EV/OCF
for Pharmaron Beijing Co Ltd.

Provide EV/FCFF
for Pharmaron Beijing Co Ltd.

Provide EV/IC
for Pharmaron Beijing Co Ltd.

Show me price targets
for Pharmaron Beijing Co Ltd made by professional analysts.

What are the Revenue projections
for Pharmaron Beijing Co Ltd?

How accurate were the past Revenue estimates
for Pharmaron Beijing Co Ltd?

What are the Net Income projections
for Pharmaron Beijing Co Ltd?

How accurate were the past Net Income estimates
for Pharmaron Beijing Co Ltd?

What are the EPS projections
for Pharmaron Beijing Co Ltd?

How accurate were the past EPS estimates
for Pharmaron Beijing Co Ltd?

What are the EBIT projections
for Pharmaron Beijing Co Ltd?

How accurate were the past EBIT estimates
for Pharmaron Beijing Co Ltd?

Compare the revenue forecasts
for Pharmaron Beijing Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Pharmaron Beijing Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Pharmaron Beijing Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Pharmaron Beijing Co Ltd compared to its peers.

Compare the P/E ratios
of Pharmaron Beijing Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Pharmaron Beijing Co Ltd with its peers.

Analyze the financial leverage
of Pharmaron Beijing Co Ltd compared to its main competitors.

Show all profitability ratios
for Pharmaron Beijing Co Ltd.

Provide ROE
for Pharmaron Beijing Co Ltd.

Provide ROA
for Pharmaron Beijing Co Ltd.

Provide ROIC
for Pharmaron Beijing Co Ltd.

Provide ROCE
for Pharmaron Beijing Co Ltd.

Provide Gross Margin
for Pharmaron Beijing Co Ltd.

Provide Operating Margin
for Pharmaron Beijing Co Ltd.

Provide Net Margin
for Pharmaron Beijing Co Ltd.

Provide FCF Margin
for Pharmaron Beijing Co Ltd.

Show all solvency ratios
for Pharmaron Beijing Co Ltd.

Provide D/E Ratio
for Pharmaron Beijing Co Ltd.

Provide D/A Ratio
for Pharmaron Beijing Co Ltd.

Provide Interest Coverage Ratio
for Pharmaron Beijing Co Ltd.

Provide Altman Z-Score Ratio
for Pharmaron Beijing Co Ltd.

Provide Quick Ratio
for Pharmaron Beijing Co Ltd.

Provide Current Ratio
for Pharmaron Beijing Co Ltd.

Provide Cash Ratio
for Pharmaron Beijing Co Ltd.

What is the historical Revenue growth
over the last 5 years for Pharmaron Beijing Co Ltd?

What is the historical Net Income growth
over the last 5 years for Pharmaron Beijing Co Ltd?

What is the current Free Cash Flow
of Pharmaron Beijing Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Pharmaron Beijing Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Pharmaron Beijing Co Ltd

Current Assets 7.1B
Cash & Short-Term Investments 2.7B
Receivables 2.9B
Other Current Assets 1.5B
Non-Current Assets 15.9B
Long-Term Investments 968m
PP&E 10.4B
Intangibles 3.6B
Other Non-Current Assets 953.7m
Current Liabilities 3.9B
Accounts Payable 503m
Accrued Liabilities 732.6m
Short-Term Debt 556.1m
Other Current Liabilities 2.1B
Non-Current Liabilities 6.1B
Long-Term Debt 4.8B
Other Non-Current Liabilities 1.3B
Efficiency

Earnings Waterfall
Pharmaron Beijing Co Ltd

Revenue
11.8B CNY
Cost of Revenue
-7.9B CNY
Gross Profit
3.9B CNY
Operating Expenses
-2.3B CNY
Operating Income
1.6B CNY
Other Expenses
253.2m CNY
Net Income
1.9B CNY

Free Cash Flow Analysis
Pharmaron Beijing Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Pharmaron Beijing Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive 3-Year Average ROE
Positive Revenue Growth Forecast
55/100
Profitability
Score

Pharmaron Beijing Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Pharmaron Beijing Co Ltd's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
64/100
Solvency
Score

Pharmaron Beijing Co Ltd's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Pharmaron Beijing Co Ltd

Wall Street analysts forecast Pharmaron Beijing Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Pharmaron Beijing Co Ltd is 28.36 CNY with a low forecast of 8.28 CNY and a high forecast of 39.9 CNY.

Lowest
Price Target
8.28 CNY
69% Downside
Average
Price Target
28.36 CNY
5% Upside
Highest
Price Target
39.9 CNY
47% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Pharmaron Beijing Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Pharmaron Beijing Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one Pharmaron Beijing Co Ltd stock?

The intrinsic value of one Pharmaron Beijing Co Ltd stock under the Base Case scenario is 39.38 CNY.

Is Pharmaron Beijing Co Ltd stock undervalued or overvalued?

Compared to the current market price of 27.07 CNY, Pharmaron Beijing Co Ltd is Undervalued by 31%.

Back to Top